BRIEF-Apimeds Pharmaceuticals Us Inc Says IPO Price Range Expected Between $4.00 And $5.00-March 2024-www.financetom.com

BRIEF-Apimeds Pharmaceuticals Us Inc Says IPO Price Range Expected Between $4.00 And $5.00

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Apimeds Pharmaceuticals Us Inc Says IPO Price Range Expected Between $4.00 And $5.00

Jan 29, 2025 4:00 PM

Jan 29 (Reuters) -

* APIMEDS PHARMACEUTICALS US INC - IPO PRICE RANGE EXPECTED

BETWEEN $4.00 AND $5.00

* APIMEDS PHARMACEUTICALS US INC SEES IPO OF UP TO 4.5

MILLION

SHARES OF COMMON STOCK

Source text:

Further company coverage: [ ]

Previous page： Sonos Pick of the Week at Smart Insider Following CEO Thomas Conrad's Stock Purchase Next page： Gloo Acquires XRI Global, Unlocking Advanced Multilingual and Voice AI Capabilities to Expand Market Opportunity

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Sonos Pick of the Week at Smart Insider Following CEO Thomas Conrad's Stock Purchase

Nov 25, 2025

08:14 AM EST, 11/25/2025 (MT Newswires) -- Sonos ( SONO ) was Smart Insider's stock pick of the week after the company's President and Chief Executive Thomas Conrad acquired $1 million worth of Sonos ( SONO ) shares for $16.17 apiece on Nov. 17, raising his stake by 26%. Conrad first bought $1 million worth of the shares in August...

Gloo Acquires XRI Global, Unlocking Advanced Multilingual and Voice AI Capabilities to Expand Market Opportunity

Nov 25, 2025

Strategic acquisition will accelerate growth by embedding advanced multilingual AI across the Gloo ( GLOO ) platform BOULDER, Colo., Nov. 25, 2025 /PRNewswire/ -- Gloo ( GLOO ) , a technology platform serving the faith and flourishing ecosystem, announced it has acquired XRI Global, an AI company pioneering voice AI and multilingual technologies designed to engage people across thousands of...

Abercrombie & Fitch Fiscal Q3 Adjusted Net Income Falls, Sales Rise; Full-Year Guidance Narrowed

Nov 25, 2025

08:07 AM EST, 11/25/2025 (MT Newswires) -- Abercrombie & Fitch ( ANF ) reported fiscal Q3 adjusted net income Tuesday of $2.36 per diluted share, down from $2.47 a year earlier. Analysts polled by FactSet expected $2.17. Net sales for the quarter ended Nov. 1 were $1.29 billion, compared with $1.21 billion a year earlier. Analysts surveyed by FactSet expected...

Electra Battery Materials Signs Cooperation Agreement with Positive Materials

Nov 25, 2025

08:14 AM EST, 11/25/2025 (MT Newswires) -- Electra Battery Materials (ELBM.V) traded 1% higher at last look Tuesday in Nasdaq pre-market trading as the company signed a supply chain cooperation agreement with Positive Materials, a provider of cathode active material manufacturing (pCAM) technology. As part of the agreement, the two companies will evaluate opportunities to integrate Electra's battery-grade cobalt sulfate...